Latest Articles

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.

Regulatory guidance relating to analytical procedures is in the process of changing to a lifecycle approach to ensure that procedures are suitable for intended use across all phases of the drug development life cycle.

This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.

Predatory conferences are the ramshackle distant cousin of your regular scientific event, a Fyre Festival of science (without the involvement of Ja Rule). It is getting harder to separate fake conferences from real ones. Given this deluge of dodgy science, we have created a guide to spotting and avoiding predatory conferences.

Cryo electron microscopy (cryo EM) has revolutionized our understanding of the intricate molecular machinery that governs life. In this article, we discuss what cryo EM is, how it works, it's strengths, limitations and applications.

This article explores how targeting the language of cancer cell communication could provide new ways to stop tumor growth and prevent drug resistance.

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.

Last week, conclusions from an upcoming report by the International Agency for Research on Cancer (IARC) were leaked. Reuters reported that the IARC was set to list the sweetener aspartame as a “possible carcinogen”. What does aspartame’s new designation mean, and should it alter your food choices?

This article will discuss progress on the development of the Immune Cell Atlas, the different techniques and technologies contributing to its development and some of the interesting findings that are coming out of the project.

Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.